Evidence map›Paper›PMID 29378937›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

High integrin α

Xianchi Dong, Bo Zhao, Fu-Yang Lin, Chafen Lu, Bruce N Rogers, Timothy A Springer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Exploring the role of ITGB6: fibrosis, cancer, and other diseases.Apoptosis : an international journal on programmed cell death · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. New perspectives on integrin-dependent adhesions.Current opinion in cell biology · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xianchi DongChildren's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Bo ZhaoChildren's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Fu-Yang LinMorphic Therapeutic, Waltham, MA 02451.
Chafen LuChildren's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Bruce N RogersMorphic Therapeutic, Waltham, MA 02451.
Timothy A SpringerChildren's Hospital Boston and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; springer_lab@crystal.harvard.edu.

Funding

TGF-beta latency and activationR01AR067288 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI SPRINGER, TIMOTHY A · 2015 to 2019
$1.9M
NIAMS NIH HHS R01 AR067288
6 · The paper itself

Abstract

The role of the hybrid domain in integrin affinity regulation is unknown, as is whether the kinetics of ligand binding is modulated by integrin affinity state. Here, we compare cell surface and soluble integrin α

Indexed as

Protein ConformationAntigens, NeoplasmBinding SitesCytoskeletonHumansIntegrinsLigandsManganeseModels, MolecularProtein BindingSequence DeletionTransforming Growth Factor beta1Antigens, Neoplasmintegrin alphavbeta6IntegrinsLigandsManganeseTGFB1 protein, humanTransforming Growth Factor beta1affinityintegrinTGF-β

Identifiers

PMID29378937
PMCPMC5816193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.